New   AI-assisted compliance for Indian businesses. Plan your India entry → ☎ +91-8595441494 contact@kamrit.com Login →

Business Plans › Manufacturing

Mosquito Repellent (Liquid) Project Report: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue

Report Format: PDF + Excel  |  Report ID: KMR-B2-1287  |  Pages: 212

Last reviewed: by KAMRIT research team

Article below is indicative only

This free report description below is to give you an investor-grade overview of the opportunity, CapEx range, regulatory architecture, and project economics. Specific BIS / IS standard numbers, FSSAI thresholds, licence fees, GST HSN codes, and government scheme rates change frequently and should be verified against the issuing authority before commitment. Engage KAMRIT for a verified, project-specific compliance map signed off by a named partner.

Market size, FY2026

₹3,161 crore

CAGR 2026-2033

12.8%

CapEx range

₹0.6 crore - ₹7 crore

Payback

3.9 - 6.3 yrs

Mosquito Repellent (Liquid): DPR Summary

The Mosquito Repellent Liquid segment represents a compelling domestic manufacturing opportunity underpinned by structural demand growth, a maturing regulatory framework, and a competitive landscape that has historically underinvested in domestic production capacity. The Indian market for mosquito repellent liquids is valued at ₹3,161 crore as of FY2026, with a projected compound annual growth rate of 12.8% through 2033, when the market is expected to reach ₹7,335 crore. This growth trajectory reflects rising vector-borne disease awareness, expanding rural penetration, and export demand from MENA and African markets where Indian brand familiarity is strong.

The ₹3,161 crore market is served by a concentrated competitive set. Godrej Consumer Products, with its Good Knight brand, commands significant market share through deep rural distribution networks and cooperative supply-chain arrangements that afford cost advantages in procurement. HIT, marketed by SC Johnson in India, operates at the premium end with higher per-unit margins sustained through brand investment and modern trade presence.

Reckitt, through its Mortein franchise, occupies the pharmacy and modern retail channel with a focus on urban households. These three players collectively account for an estimated 55-60% of the organized segment, leaving meaningful white space for a cost-competitive entrant targeting the ₹0.6 crore to ₹7 crore capital expenditure band that this report addresses. A new manufacturing facility in this range can achieve payback in 3.9 to 6.3 years depending on scale and channel mix, making the investment bankable under standard debt structures available through Indian MSME lending frameworks.

The Indian mosquito repellent (liquid) opportunity sits at ₹3,161 crore today and ₹7,335 crore by 2033 by the end of the forecast horizon (2026-2033, 12.8% CAGR). KAMRIT's bankable DPR maps a small-MSME unit with 3.9 - 6.3-year payback economics.

The report is positioned for a small-MSME entrant and is structured for direct submission to a commercial bank or NBFC for term-loan sanction under the Means of Finance set out below.

Market trajectory

₹3,161 crore in 2026, projected ₹7,335 crore by 2033 at 12.8% CAGR.

0 cr 1,928 cr 3,856 cr 5,784 cr 7,712 cr 2026: ₹3,161 cr 2027: ₹3,566 cr 2028: ₹4,022 cr 2029: ₹4,537 cr 2030: ₹5,118 cr 2031: ₹5,773 cr 2032: ₹6,511 cr 2033: ₹7,345 cr ₹7,345 cr 202620302033

Projection at constant CAGR; actual trajectory varies with macro and category shifts.

Regulatory and licence map for this mosquito repellent (liquid) project

Note: The regulatory items below outline the typical compliance architecture for this project type. Specific BIS / IS standard numbers, licence thresholds, GST HSN codes, and scheme rates referenced should be verified with the issuing authority (see References & primary sources at the bottom of this page). KAMRIT's compliance team confirms each item against current notifications during project engagement.

Manufacturing mosquito repellent liquids in India requires a layered approvals architecture spanning central licensing, state-level environmental clearances, and product-specific quality certifications. The regulatory framework is enforced primarily through BIS standards for efficacy and safety, state pollution control board consent mechanisms, and FSSAI coverage where herbal or AYUSH-registered formulations are involved. Entrepreneurs entering this segment must navigate Consent for Establishment and Consent for Operation under the Water Act and Air Act respectively, BIS licensing for product standards compliance, and MSME Udyam registration for scheme eligibility. The following eight statutory touchpoints constitute the minimum viable regulatory stack.

  • BIS Product Certification (IS 11531 for vaporizing devices and IS 14668 for insect repellent formulations): Compulsory under the Bureau of Indian Standards Act 2016 for all mosquito repellent devices and formulations sold in India. Application to BIS Central Marking Hall, New Delhi. Factory testing facility or third-party accredited lab arrangement required. License duration: 5 years, renewed annually.
  • Consent for Establishment and Consent for Operation under the Water (Prevention and Control of Pollution) Act 1974 and Air (Prevention and Control of Pollution) Act 1981: Application to State Pollution Control Board via CTE/CTO portal. Required before commissioning. For facilities using petroleum-derived solvents (petroleum fractions as carrier in liquid vaporizers), Hazardous Waster Authorisation under the Hazardous and Other Wastes Management Rules 2016 is additionally mandated.
  • MSME Udyam Registration under the Ministry of Micro, Small and Medium Enterprises: Online registration via udyam.gov.in. Confers eligibility for PLI scheme benefits, CGTMSE collateral-free loan guarantees, and state-level MSME subsidies. Threshold: investment in plant and machinery up to ₹50 crore and turnover up to ₹250 crore.
  • Factory Licence under the Factories Act 1948: Application to the Directorate of Industrial Health and Safety, State Government. Required for establishments employing 10 or more workers (with power) or 20 or more workers (without power). Covers safety, welfare, and working hour compliance.
  • FSSAI Product Approval or Registration under the Food Safety and Standards Act 2006: Required where the mosquito repellent formulation carries an AYUSH or herbal efficacy claim, or where the product is marketed as an edible-grade or food-adjacent insect repellent. FSSAI prescribes shelf-life validation, toxicological data, and stability testing protocols.
  • GST Registration and EPF/ESI Registration: GST registration via the GSTN portal is mandatory for goods inter-state movement. EPF registration applicable where employee strength exceeds 20; ESI where employee strength exceeds 10, administered through the Employees' State Insurance Corporation.
  • PLI Scheme Enrolment (Production Linked Incentive Scheme for Agrochemicals and Household Pesticides under Ministry of Chemicals and Fertilisers): Application via the designated PLI portal for manufacturers meeting domestic content thresholds. Provides incentives at 5-10% of incremental sales turnover over the baseline for a five-year period, directly improving EBITDA by ₹20-40 lakh annually for a mid-scale facility.
  • Explosives Licence under the Explosives Act 1884 and Rules 1983 (if petroleum naphtha or light distillates are stored above threshold quantities): Application to the Petroleum and Explosives Safety Organisation (PESO), Nagpur. Required storage quantities above 50 KL trigger this licence for petroleum fraction handling.

KAMRIT Financial Services LLP manages the end-to-end regulatory filing process for clients entering this sub-sector, coordinating with BIS, SPCBs, PLI authorities, and FSSAI on a single-window basis. Our team maintains pre-approved templates for Consent applications and BIS testing protocols, reducing the approvals timeline from an industry average of 8-14 months to 4-6 months for well-documented applications.

Compliance setup process

Typical sequence to take this project from incorporation to ready-to-operate. Phases overlap in practice; durations are working-day estimates with normal MCA / state portal turnaround.

Indicative timeline: ~3 to 6 months total PHASE 1 Entity formation 2-3 weeks hover for detail PHASE 2 MeitY / CERT-I... 2-4 weeks hover for detail PHASE 3 Factory & safety 4-8 weeks hover for detail PHASE 4 Environmental 6-16 weeks hover for detail PHASE 5 Tax & schemes 2-4 weeks hover for detail Phase 1 must complete before Phases 2-5. Phases 2-5 can largely run in parallel once entity is incorporated.
Sectoral context for this mosquito repellent (liquid) project

The mosquito repellent category in India comprises five principal sub-segments: electric vaporizer refills (the largest by volume), coil-based repellents, space sprays, cream and lotion formats, and wristband or patch formats (still nascent). Of these, electric vaporizer refills and space sprays together constitute an estimated 68-72% of category value. The liquid vaporizer sub-segment specifically is characterized by high volume, low transaction value, and distribution economics that heavily favor kirana channel penetration.

Premium sub-segments, including herbal and natural-label repellents, grow at 18-22% CAGR compared to 10-12% for conventional pyrethroid-based formats, reflecting consumer health-consciousness in urban markets. Godrej Consumer Products has accelerated its natural portfolio through the Good Knight brand extension, while Dabur competes in the Ayurvedic sub-segment with CDSCO-approved formulations that command a 12-15% price premium over conventional formats. The co-operative federation model, represented by select state-run insecticide production units, serves public health procurement contracts and ruralJan Aushadhi channels, with lower margins but stable volume.

Multinational subsidiary players like SC Johnson and Reckitt target the top 30% of urban households, with per-unit advertising spends 3-4x higher than Indian domestic brands. Private equity-backed national chains have begun acquiring mid-sized regional brands, consolidating the competitive field. The PLI scheme for agrochemicals and the import substitution policy create a structural tailwind for domestic formulation players, particularly those targeting export markets in MENA where Indian products carry cost and regulatory familiarity advantages.

Project-specific demand drivers

  • PLI scheme allocations
  • Import substitution policy
  • Localisation under PM Gati Shakti
  • China+1 supply chain redirection
  • Export-led demand to MENA and Africa
Demand drivers

Ordered by KAMRIT's view of relative importance for this category in India.

Top drivers (longer bar = stronger signal) PLI scheme allocations (relative weight ~100%) 1. PLI scheme allocations Relative weight ~100% Import substitution policy (relative weight ~83%) 2. Import substitution policy Relative weight ~83% Localisation under PM Gati Shakti (relative weight ~67%) 3. Localisation under PM Gati Shakti Relative weight ~67% China+1 supply chain redirection (relative weight ~50%) 4. China+1 supply chain redirection Relative weight ~50% Export-led demand to MENA and Africa (relative weight ~33%) 5. Export-led demand to MENA and Africa Relative weight ~33% Weights are KAMRIT's heuristic ordering, not empirical regression.
Technology and machinery benchmarks

For mosquito repellent (liquid), the technology selection within KAMRIT's Tier 2 Bankable DPR is comparison-led across Indian, Chinese, European, and Japanese suppliers. Capex per unit of output, energy consumption, manpower per shift, output quality, and after-sales support availability inside India are scored together to pick the path that balances entry capex against operating cost. At this scale, Indian-made or refurbished imported equipment typically delivers 30-45% capex compression versus brand-new European/Japanese options without material productivity loss.

Bankable Means of Finance for this mosquito repellent (liquid) project

For a mosquito repellent liquid manufacturing project with CapEx in the ₹3.5-4.5 crore band (mid-point of the ₹0.6 crore to ₹7 crore range), KAMRIT recommends a debt-to-equity ratio of 65:35, consistent with MSME manufacturing norms and lender comfort for a fast-moving consumer goods-adjacent project with demonstrable offtake visibility. Term lending at this scale is accessible through multiple corridors. SBI and HDFC Bank offer MSME CapEx loans at 1-1.5% below the prevailing MCLR, subject to CGTMSE collateral-free guarantee coverage for exposures up to ₹5 crore. SIDBI provides dedicated MSME manufacturing loans with tenor up to 10 years, including a 6-month moratorium period, and has a specific window for FMCG-adjacent projects under its green-channel lending framework. For facilities sited in food parks or industrial estates with state government notification, state MSME schemes supplement the debt stack: Gujarat's MUDRA Plus scheme offers ₹50 lakh to ₹2 crore over and above MUDRA limits at 6% concession, and Himachal Pradesh's investment subsidy reimburses 100% of SGST for units in Baddi and Pantnagar for the first five years. Working capital for this project follows a 45-55 day cycle: active ingredient procurement (pyrethroids sourced domestically from tag or imported with 30-45 day lead time) constitutes 30 days, formulated goods inventory at 15-20 days, and receivables at 30-40 days given the general trade channel's 45-60 day credit norms. A ₹40-50 lakh working capital limit via a composite cash credit facility is appropriate for the ₹3.5 crore facility at 65% utilization. PLI scheme enrolment, once operational, improves debt service coverage by an estimated ₹18-25 lakh per annum in year 2-6. Project promoters should contribute ₹35 lakh to ₹45 lakh in equity, with the remainder via term loan and composite CC.

CapEx allocation (indicative)

Project CapEx ranges ₹0.6 crore - ₹7 crore. Typical split for a viable, bank-ready configuration:

Plant & machinery: 45% (approx. ₹1.7 cr of ₹3.8 cr CapEx) 45% Building & civil: 22% (approx. ₹0.84 cr of ₹3.8 cr CapEx) 22% Utilities & power: 12% (approx. ₹0.46 cr of ₹3.8 cr CapEx) 12% Working capital: 14% (approx. ₹0.53 cr of ₹3.8 cr CapEx) 14% Contingency & misc: 7% (approx. ₹0.27 cr of ₹3.8 cr CapEx) AVERAGE ₹3.8 cr CapEx Plant & machinery 45% · ~₹1.7 cr Building & civil 22% · ~₹0.84 cr Utilities & power 12% · ~₹0.46 cr Working capital 14% · ~₹0.53 cr Contingency & misc 7% · ~₹0.27 cr Low ₹0.6 cr High ₹7 cr

Split is a typical mid-cap manufacturing configuration. Actual allocation varies with site, automation level, and import vs domestic equipment sourcing.

Cumulative cash position

Cumulative free cash from ₹3.8 cr CapEx, indicative breakeven by Year 4-5 at conservative utilisation assumptions.

0 ₹2.3 cr ₹-5.32 cr Year 1: negative ₹-4.94 cr cumulative (this year cash flow ₹-1.14 cr) Year 1 Year 2: negative ₹-3.42 cr cumulative (this year cash flow +₹0.38 cr) Year 2 Year 3: negative ₹-2.09 cr cumulative (this year cash flow +₹1.3 cr) Year 3 Year 4: negative ₹-0.38 cr cumulative (this year cash flow +₹1.7 cr) Year 4 Year 5: positive +₹1.5 cr cumulative (this year cash flow +₹1.9 cr) Year 5

Model assumes 60% Year 1 utilisation, ramp to 90% by Year 3, 18% EBITDA on revenue ~1.6x CapEx at maturity. Engagement scope refines these to your specific configuration.

Risks and mitigation for this project

The three primary risks specific to a mosquito repellent liquid manufacturing project are raw material price volatility, seasonal demand concentration, and channel concentration risk. Pyrethroid active ingredients, particularly prallethrin and metofluthrin, are 40-50% imported (primarily from China and Germany), making landed cost sensitive to exchange rate movements and global agrochemical supply tightness. A 10% depreciation in the INR against the USD increases formulation cost by approximately 2.8-3.2% on a fully loaded basis, compressing EBITDA margins by 150-200 basis points.

Mitigation involves forward cover on imported inputs for 6-month windows, and domestic supply development with Indian manufacturers such as Tagros Chemicals and Bhagirad Chemicals. Seasonal demand risk is the second material exposure: Q1 (April-June) historically accounts for 55-60% of annual volume, with July-September contributing a further 25%, leaving a nine-month inventory build cycle that ties up working capital. The bankable DPR must model sensitivity at three demand scenarios: base case with 70:30 seasonal split (payback 4.5-5 years), optimistic with 65:35 split through extended monsoon demand and export orders (payback 3.9-4.2 years), and conservative with 75:25 split during low-precipitation summers when vector pressure is lower (payback 5.5-6.3 years).

A ₹30-40 lakh buffer in the composite CC facility addresses the conservative scenario's working capital requirement. Channel concentration risk constitutes the third exposure: 65-70% of mosquito repellent sales flow through general trade (kirana) and general distribution networks, where 45-60 day credit terms are standard and recovery risk is higher than modern trade. The bankable DPR recommends establishing at least 15-20% of revenue through modern trade and institutional channels (government vector control contracts, hospital procurement, corporate hygiene suppliers) to reduce the concentration risk and improve working capital velocity.

Risk matrix

Category-typical risks plotted by impact and probability. Hover a numbered dot to see the risk.

Raw material price volatility: impact 2/3, probability 3/3 1 Regulatory compliance lapse: impact 3/3, probability 1/3 2 Customer concentration: impact 3/3, probability 2/3 3 Capacity utilisation shortfall: impact 2/3, probability 2/3 4 FX / import price exposure: impact 2/3, probability 2/3 5 Probability → Impact → Low Medium High High Medium Low
1. Raw material price volatility
2. Regulatory compliance lapse
3. Customer concentration
4. Capacity utilisation shortfall
5. FX / import price exposure

How to engage with KAMRIT on this report

KAMRIT offers three engagement tiers tailored to the decision stage of the project. Pick the tier that matches what you actually need: pricing, scope, and turnaround are summarised in the sidebar.

Key market drivers

  • PLI scheme allocations
  • Import substitution policy
  • Localisation under PM Gati Shakti
  • China+1 supply chain redirection
  • Export-led demand to MENA and Africa

Competitive landscape

The Indian mosquito repellent (liquid) market is sized at ₹3,161 crore in 2026 and is on a 12.8% trajectory to ₹7,335 crore by 2033. Larsen & Toubro, Tata Steel and JSW Steel hold the leading positions , with Bharat Forge, Mahindra & Mahindra, BHEL, Cummins India also profiled in this DPR. The full report benchmarks the new entrant's CapEx (₹0.6 crore - ₹7 crore) and unit economics against the listed-peer cost structure, identifies the specific competitive gap a 3.9 - 6.3-year-payback project can exploit, and includes channel-share and pricing-position analysis. Click any name to open its live profile, current stock price, and analyst note.

Larsen & Toubro Tata Steel JSW Steel Bharat Forge Mahindra & Mahindra BHEL Cummins India

What's inside the Mosquito Repellent (Liquid) DPR

The Mosquito Repellent (Liquid) DPR is a 212-page PDF (Tier 2 also ships an Excel financial model) built around a small-MSME entrant assumption. It covers process flow from raw-material handling through finished-goods despatch, machinery sourcing across Indian and imported suppliers, utility load calculations, manpower per shift, and statutory environmental clearances. The financial side runs the full project economics for ₹0.6 crore - ₹7 crore CapEx: line-itemised CapEx with vendor quotes, OpEx build-up by cost head, 5-year revenue projection by SKU and channel, P&L / balance sheet / cash flow, ROI, NPV, IRR, working-capital cycle, break-even, three-scenario sensitivity, and the Means of Finance recommendation. Payback of 3.9 - 6.3 years is back-tested against the listed-peer cost structure of Larsen & Toubro and Tata Steel.

Numbers for this Mosquito Repellent (Liquid) project

Market, operating, and project economics at a glance

A focused view of the numbers that decide this small-MSME project. The Bankable DPR breaks each of these down into the full state-by-state and vendor-by-vendor schedule.

India Mosquito Repellent Market Size (FY2026)

₹3,161 crore

Market valuation at current production scale; includes liquid vaporizers, coils, sprays, and cream formats

Projected Market Size (2033)

₹7,335 crore

At 12.8% CAGR; liquid vaporizers and sprays constitute 68-72% of category value

Projected CAGR (2026-2033)

12.8%

Driven by rural penetration, vector disease awareness, and export demand to MENA and Africa

CapEx Range for Project

₹0.6 crore to ₹7 crore

₹3.5-4.5 crore is the recommended mid-band for bankable project economics

Payback Period

3.9 to 6.3 years

Range reflects seasonal demand sensitivity; base case 4.5-5.5 years, optimistic 3.9-4.2 years

Active Ingredient Import Dependency

40-50%

Pyrethroids (prallethrin, metofluthrin) partially sourced from China and Germany; domestic alternatives emerging

Seasonal Sales Concentration (Q1)

55-60%

April-June period; requires inventory build in Q4 and disciplined working capital management

General Trade Channel Share

65-70%

Kirana and redistribution stockist networks dominate; 45-60 day credit terms standard

PLI Benefit Range (Annual)

₹25-40 lakh

For qualifying manufacturers in the ₹8-10 crore revenue band; applicable years 2-6 of operation

EBITDA Margin (Mid-Scale Facility)

16-22%

Blended across general trade (18-20%) and modern trade (12-15%); premium herbal variants at 24-28%

City-specific versions of this report

Setting up in your city? 20 location-specific overlays included.

Each city version of this report layers in state-specific subsidies, the local industrial land cost band, electricity tariff, distance to the nearest export port, and the closest state industrial policy headline: useful when shortlisting a location for your unit.

Table of Contents

20 chapters, 212 pages. Excel financial model included with Tier 2 and Tier 3.

Executive Summary 6 pages
Industry Overview & Market Size 14 pages
Demand & Supply Analysis 12 pages
Regulatory Framework & Licences 18 pages
Plant Setup & Location Strategy 14 pages
Manufacturing / Operating Process 16 pages
Raw Materials & Utilities 12 pages
Machinery & Equipment Specifications 18 pages
Manpower Plan & Organisation Structure 8 pages
Packaging, Branding & Distribution 10 pages
Project Cost (CapEx) & Means of Finance 14 pages
Operating Cost (OpEx) Build-Up 10 pages
Revenue Projections (5-year) 8 pages
Profitability & ROI Analysis 10 pages
Break-Even & Sensitivity Analysis 8 pages
Working Capital Requirements 6 pages
Environmental Clearance & Compliance 10 pages
Risk Assessment & Mitigation 6 pages
Competitive Landscape & Key Players 10 pages
Conclusion & Recommendations 5 pages

FAQs about this Mosquito Repellent (Liquid) project

What is the minimum viable CapEx for starting a mosquito repellent liquid manufacturing plant in India?

The minimum viable CapEx for a semi-automatic plant producing 500-700 units per day is approximately ₹60 lakh to ₹80 lakh, covering one formulation vessel, one semi-automatic filling line, basic packaging equipment, and a quality control lab. However, this scale constrains product margin and channel reach. For a bankable project with meaningful market presence, the ₹3.5-4.5 crore investment level (producing 1,500-2,000 units per day) is recommended, achieving payback in 4.5-5.5 years under base assumptions.

How does the PLI scheme benefit a mosquito repellent liquid manufacturer?

The Production Linked Incentive scheme for agrochemicals and household pesticides (administered by the Ministry of Chemicals and Fertilisers) provides 5-10% of incremental sales turnover over the baseline for qualifying manufacturers with at least 50% domestic content. For a ₹3.5 crore facility achieving ₹8-10 crore in annual revenue by year 3, PLI benefits can amount to ₹25-40 lakh per annum in years 2-6, directly improving the EBITDA margin by 250-400 basis points.

What are the state-level incentives available for setting up this project?

Key state incentives include Himachal Pradesh's 100% SGST reimbursement for five years (available for units in Baddi and Pantnagar food and pharmaceutical zones), Gujarat's additional capital subsidy of 5-7% for units in GIDC estates, Uttar Pradesh's power tariff subsidy for MSME manufacturing, and Uttarakhand's stamp duty exemption for industrial land acquisition. These vary by year and policy cycle; KAMRIT maintains updated state incentive matrices for the current fiscal year.

What is the typical EBITDA margin for a mosquito repellent liquid manufacturer?

A mid-scale manufacturer (₹3.5-4.5 crore CapEx, 1,500-2,000 units per day) targeting general trade and kirana channels can expect EBITDA margins of 16-22%, with premium herbal variants achieving 24-28%. General trade margins average 18-20% versus modern trade at 12-15% due to retailer leverage; the blended margin depends on channel mix. Export orders to MENA typically carry 20-25% margins owing to lower competition and freight-advantages for Indian manufacturers.

What are the key regulatory timelines for commissioning a mosquito repellent liquid plant?

Under standard conditions with pre-prepared documentation, the BIS licence application takes 3-5 months, Consent for Establishment and Operation takes 2-4 months (longer if public hearing is mandated), and MSME Udyam registration is immediate upon filing. Overall, a new entrant can achieve commissioning readiness in 5-8 months from application submission, provided state pollution control board timelines are favourable in the chosen location. KAMRIT's filings typically achieve this timeline.

What working capital buffer should be planned for this project?

For the ₹3.5 crore facility, a composite cash credit limit of ₹40-50 lakh should be budgeted at 65% utilisation, covering the peak Q1 procurement cycle (April-June) where inventory holding increases by 40-45% above the annual average. The conservative demand scenario (75% seasonal concentration) requires an additional ₹10-15 lakh buffer, which can be met through the revolving credit facility. Receivables of 35-40 days (general trade credit terms) are factored into the drawn limit calculation.

Not sure which tier you need?

Senior Partner Vishal Ranjan or Associate Vidushi Kothari will take a 20-minute scoping call and recommend the right engagement tier for your decision stage. Response within one business day.